Carlsbad, CA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and ...
KAILUA, Hawaii (Island News) -- Developer and property owner Alexander & Baldwin proposed redevelopment plans for a registered Hawaii Historic Landmark, Pali Lanes, which closed down over two years ...
HONOLULU (HawaiiNewsNow) - It’s been nearly two years since an iconic Kailua landmark closed its doors for good. That’s got community members wondering what the future of Pali Lanes actually looks ...
Palisade Bio (PALI) announced that the first patients have been dosed in its Phase 1b clinical study evaluating PALI-2108, a first-in-class, ileocolonic-targeted PDE4 inhibitor prodrug, for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback